Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69,268 | 47,254 | 30,414 | 206,152 | 4,960 |
| Marketable Securities | 306,350 | 287,110 | 167,524 | 161,985 | 112,904 |
| Receivables | 36,078 | 7,122 | 12,454 | 5,559 | 6,298 |
| TOTAL | $421,542 | $353,153 | $218,515 | $378,182 | $128,568 |
| Non-Current Assets | |||||
| PPE Net | 21,940 | 24,621 | 22,550 | 12,935 | 9,633 |
| Investments And Advances | 0 | 0 | 68,775 | 0 | 15,609 |
| Other Non-Current Assets | 27,254 | 29,170 | 31,568 | 2,994 | 2,560 |
| TOTAL | $49,194 | $53,791 | $122,893 | $15,929 | $27,802 |
| Total Assets | $470,736 | $406,944 | $341,408 | $394,111 | $156,370 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,061 | 12,500 | 9,375 | N/A | 1,000 |
| Accounts payable and accrued liabilities | 9,440 | 4,797 | 6,009 | 5,544 | 5,584 |
| Accrued Expenses | 53,159 | 27,906 | 19,819 | 8,823 | 6,017 |
| Other current liabilities | N/A | N/A | N/A | 627 | 901 |
| TOTAL | $93,746 | $66,547 | $41,736 | $29,597 | $32,967 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 3,771 | 15,738 | 24,545 | 8,876 |
| Deferred Revenues | 20,666 | 16,759 | 5,496 | 14,603 | 19,465 |
| aiOther Non-Current Liabilities | 173,962 | 29,693 | 31,370 | 481 | 134 |
| TOTAL | $227,341 | $123,349 | $47,108 | $32,466 | $25,614 |
| Total Liabilities | $321,087 | $189,896 | $88,844 | $62,063 | $58,581 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,442 | 60,161 | 46,381 | 45,892 | 23,099 |
| Common Shares | 61 | 58 | 46 | 46 | 23 |
| Retained earnings | -559,408 | -452,615 | -333,411 | -227,873 | -195,745 |
| Other shareholders' equity | 21 | -618 | -314 | 129 | 165 |
| TOTAL | $149,649 | $217,048 | $252,564 | $332,048 | $97,789 |
| Total Liabilities And Equity | $470,736 | $406,944 | $341,408 | $394,111 | $156,370 |